Could Viagra Help Fight Cancer? Study Finds Surprising Cholesterol Link

Key Points:

• A new study published in Cancer Research reveals that sildenafil (Viagra) disrupts cholesterol handling in cancer cells, trapping cholesterol inside lysosomes and limiting tumor cells' ability to metastasize, as shown in mouse models of breast, lung, and colon cancer.
• Sildenafil blocks the PDE5a enzyme, causing cGMP buildup that interferes with NPC1 protein function, preventing cholesterol from reaching the cell membrane and weakening cancer cells' structural integrity and invasiveness.
• Combining sildenafil with statins, which reduce cholesterol production, further decreases cancer cell movement and viability in lab experiments and mouse models, suggesting a synergistic effect that targets cancer cells more than healthy cells.
• Analysis of health records from over 40,000 male cancer patients found that those who used both sildenafil and statins had a 31% lower risk of death within five years compared to non-users, though the retrospective nature of the study limits definitive conclusions.
• These findings support the potential for clinical trials to evaluate sildenafil and statin combination therapy as an adjunct to existing cancer treatments, highlighting a promising new use for a well-established drug with a strong safety record.